In the interest of predictability, efficiency and consistency, a detailed procedure should be laid down for assessing whether an active substance can be approved. The information to be submitted by interested parties for the purposes of approval of a substance should be specified. In view of the amount of work connected with the approval procedure, it is appropriate that the evaluation of such information be performed by a Member State acting as a rapporteur for the Community. To ensure consistency in evaluation, an independent scientific review should be performed by the European Food Safety Authority established by Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety [OJ L 31, 1.2.2002, p. 1.] (the Authority). It should be clarified that the Authority performs a risk assessment whilst the Commission should perform the risk management role and take the final decision on an active substance. Provisions should be included to ensure the transparency of the evaluation process.
Recital 12, Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October…
Judgment of the General Court (Seventh Chamber) of 15 February 2023 (Extracts). UPL Europe Ltd and Indofil Industries (Netherlands) BV v EurDecision
Moreover, as is apparent from recital 12 of Regulation No 1107/2009, in the procedure for approval of plant protection products at EU level, it is the Commission which assumes the risk management role and takes the final decision …
15 Feb 2023 · 62020TJ0742
Judgment of the Court (Ninth Chamber) of 4 October 2024. UPL Europe Ltd and Indofil Industries (Netherlands) BV v European Commission.Decision
Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ 2009 L 309, p. …
4 Oct 2024 · 62023CJ0262
Judgment of the General Court (Seventh Chamber, Extended Composition) of 4 October 2023. Ascenza Agro, SA and Industrias Afrasa, SA v EuropeDecision
In particular, in the field of the authorisation of plant protection products and their active substances, EFSA carries out scientific risk assessment functions, as is apparent from recital 12 of Regulation No 1107/2009 and from Article 12 …
4 Oct 2023 · 62020TJ0077
Judgment of the General Court (Fourth Chamber) of 14 December 2018. Arysta LifeScience Netherlands BV, formerly Chemtura Netherlands BV v EuDecision
According to recital 12 of Regulation No 1107/2009: ‘... Provisions should be included to ensure the transparency of the evaluation process.’
14 Dec 2018 · 62015TJ0725
Judgment of the General Court (Seventh Chamber) of 9 February 2022. Taminco BVBA and Arysta LifeScience Great Britain Ltd v European CommissDecision
Finally, as is apparent from recital 12 of Regulation No 1107/2009, the Commission assumes the role of risk management and takes the final decision on an active substance. In the context of that risk management role, the Commission …
9 Feb 2022 · 62018TJ0740
Opinion of Advocate General Medina delivered on 28 September 2023. Pesticide Action Network Europe (PAN Europe) v College voor de toelating Decision
Recital 12 of Regulation No 1107/2009 clarifies that EFSA ‘performs a risk assessment’ whilst the Commission ‘should perform the risk management role and take the final decision on an active substance’. The wording of Article 36 of …
28 Sep 2023 · 62022CC0308
Ordonnance du Tribunal (dixième chambre) du 8 avril 2021. Comité de recherche et d’information indépendantes sur le génie génétique (CRII-GEDecision
En effet, le règlement n o 1107/2009 confie à la Commission le rôle de la gestion des risques et de la prise de décision définitive concernant une substance active, ainsi qu’il ressort du considérant 12 de celui-ci. La procédure …
8 Apr 2021 · 62020TO0496